Literature DB >> 17114381

Effects of two doses of buprenorphine four or six hours apart on nociceptive thresholds, pain and sedation in dogs after castration.

L S Slingsby1, P M Taylor, A E Waterman-Pearson.   

Abstract

Twenty-eight dogs were randomly allocated into two groups. They were premedicated with either 10 or 20 microg/kg buprenorphine and 0.05 mg/kg acepromazine administered intramuscularly, and then anaesthetised with intravenous thiopentone to effect and maintained with isoflurane in 100 per cent oxygen. The dogs underwent routine castration, and a second dose of 10 microg/kg buprenorphine was administered four hours after the first or 20 microg/kg six hours after the first dose. Levels of pain and sedation were scored on a visual analogue scale and in terms of the dogs' requirement for rescue analgesia, and mechanical nociceptive thresholds were measured at the hock and wound at premedication and one, two, three, four, five, six, seven, 10 and 21 to 22 hours later. Pain scores were low in both groups, with a trend for lower scores in the high dose group; administration of the second dose of buprenorphine further decreased the pain scores. Buprenorphine produced good preoperative sedation and the level of sedation decreased over time after surgery. Administration of the second high dose of buprenorphine did not increase the level of sedation. Both doses of buprenorphine prevented hyperalgesia at the wound and hock postoperatively. Three dogs given the low dose and one dog given the high dose required rescue analgesia with carprofen.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17114381     DOI: 10.1136/vr.159.21.705

Source DB:  PubMed          Journal:  Vet Rec        ISSN: 0042-4900            Impact factor:   2.695


  2 in total

1.  Development of a canine nociceptive thermal escape model.

Authors:  Kirsten Wegner; Kjersti A Horais; Nicolle A Tozier; Michael L Rathbun; Yuri Shtaerman; Tony L Yaksh
Journal:  J Neurosci Methods       Date:  2007-09-29       Impact factor: 2.390

2.  Pharmacokinetics and analgesic effects of intravenous, intramuscular or subcutaneous buprenorphine in dogs undergoing ovariohysterectomy: a randomized, prospective, masked, clinical trial.

Authors:  Paulo Vinicius Steagall; Hélène Louise Marcelle Ruel; Tomoyo Yasuda; Beatriz Paglerani Monteiro; Ryota Watanabe; Marina Cayetano Evangelista; Francis Beaudry
Journal:  BMC Vet Res       Date:  2020-05-24       Impact factor: 2.741

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.